Dr. Gabriel Oluseun Arimoro, MD

Dr. Arimoro practices at Valley Springs Behavioral Health Hospital in Holyoke, Massachusetts, part of Valley Springs Behavioral Health Hospital.

Dr. Arimoro's NPI, 1023209442, was assigned on August 9, 2007. Dr. Arimoro holds Connecticut license 045609.

Dr. Arimoro's primary practice is Valley Springs Behavioral Health Hospital, at 45 Lower Westfield Road, Holyoke, MA 01040 in Hampden County. The practice phone is (413) 315-4100.

Dr. Arimoro's primary practice is Valley Springs Behavioral Health Hospital in Holyoke, Massachusetts, part of Valley Springs Behavioral Health Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Arimoro to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arimoro practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Arimoro's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Arimoro is board certified in addiction psychiatry by the American Board of Psychiatry and Neurology. Dr. Arimoro is licensed in Connecticut.

CMS data shows 23 Medicare services from Dr. Arimoro across 1 procedure code in 2024, for 29 Medicare patients. Medicare paid $981 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Arimoro in 2024. 75% of them have anxiety, and 75% have mood disorders. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arimoro's median patient age at 37, with 49% women.

In 2024, Dr. Arimoro wrote 223 Medicare Part D claims for 14 patients. 83% of them were for generic drugs. CMS names the drug for 106 of them, across 6 drugs with 11 or more claims each, at $13,883 in total drug cost. In 2023, CMS named 86 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Arimoro for performance year 2024, reported as part of a group. Dr. Arimoro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 40 general payments to Dr. Arimoro from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $509.